Vimta Labs Share Price

NSE
VIMTALABS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Vimta Labs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
New 52W High in past week
76.2
TTM PE Ratio
Below industry Median
44.1
Price to Book Ratio
Above industry Median
6.9
Dividend yield 1yr %
Low in industry
0.2
TTM PEG Ratio
PEG TTM is much higher than 1
2.1

Vimta Labs Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Vimta Labs Ltd Quarterly Revenue

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
84.74 Cr
81.76 Cr
79.69 Cr
81.68 Cr
73.41 Cr

Vimta Labs Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
322.27 Cr
321.63 Cr
279.73 Cr
211.51 Cr
183.73 Cr

Vimta Labs Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
17.02 Cr
12.28 Cr
12.35 Cr
10.13 Cr
6.33 Cr

Vimta Labs Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
41.01 Cr
48.17 Cr
41.33 Cr
21.4 Cr
6.84 Cr

Vimta Labs Ltd shareholding Pattern

Promoter
36.9%
Foreign Institutions
3.3%
Public
59.8%
Promoter
36.9%
Foreign Institutions
5.2%
Mutual Funds
1.5%
Domestic Institutions
1.4%
Public
56.4%
Promoter
36.9%
Foreign Institutions
5.1%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
56.4%
Promoter
37%
Foreign Institutions
2.9%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.6%
Promoter
37%
Foreign Institutions
2.7%
Mutual Funds
1.5%
Domestic Institutions
1.5%
Public
58.8%
Promoter
37.2%
Foreign Institutions
2.7%
Mutual Funds
1.5%
Domestic Institutions
2.2%
Public
57.9%

Vimta Labs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
972.00
10Day EMA
955.10
12Day EMA
946.90
20Day EMA
909.50
26Day EMA
881.00
50Day EMA
792.60
100Day EMA
696.00
200Day EMA
612.00
5Day SMA
974.90
10Day SMA
951.40
20Day SMA
929.10
30Day SMA
862.90
50Day SMA
740.70
100Day SMA
651.20
150Day SMA
601.10
200Day SMA
571.60
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
44408 Rs
132890 Rs
Week Rs
82996 Rs
394296 Rs
Month Rs
72079 Rs
294972 Rs
Resistance & Support
975.22
Pivot
Resistance
First Resistance
999.88
Second Resistance
1,037.87
Third Resistance
1,062.53
Support
First Support
937.23
Second support
912.57
Third Support
874.58
Relative Strength Index
64.96
Money Flow Index
76.64
MACD
65.87
MACD Signal
70.61
Average True Range
57.23
Average Directional Index
60.70
Rate of Change (21)
25.80
Rate of Change (125)
96.87

Vimta Labs Ltd Company background

Founded in: 1990
Managing director: Harita Vasireddi
Vimta Labs Ltd., established in 1984, is Indias most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and nonGLP), clinical research, central lab, and cGMP as well as nonGMP analytical services for pharmaceutical and biopharmaceutical companies Preclinical research and testing services for medical device companies Contract research and testing for Agroscience companies Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil gas, mining etc EMI/EMC testing for electronic and electrical products.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.During the year 200607, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.In 202324, Emtac Laboratories Private Limited got amalgamated with the Company effective 01.04.2024.
Read More

Vimta Labs Ltd FAQs

Vimta Labs Ltd shares are currently priced at 993.05 on NSE and 996 on BSE as of 12/20/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Vimta Labs Ltd [VIMTALABS] share was 148.69. The Vimta Labs Ltd [VIMTALABS] share hit a 1-year low of Rs. 390.3 and a 1-year high of Rs. 1069.95.

The market cap of Vimta Labs Ltd is Rs. 2136.7 Cr. as of 12/20/2024 12:00:00 AM.

The PE ratios of Vimta Labs Ltd is 42.06 as of 12/20/2024 12:00:00 AM.

The PB ratios of Vimta Labs Ltd is 6.32 as of 12/20/2024 12:00:00 AM

You can easily buy Vimta Labs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -